PC
AEON.WS

Periscope Capital’s AEON Biopharma Inc AEON.WS Stock Holding History

Periscope Capital’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,500
Closed -$22.5K – 415
2024
Q1 		$22.5K Sell
15,500
-134,500
-90% -$82.5K 0.01% 285
2023
Q4 		$13.5K Hold
150,000
– – ﹤0.01% 373
2023
Q3 		$22.5K Sell
150,000
-342,330
-70% -$48.5K ﹤0.01% 459
2023
Q2 		$44.3K Sell
492,330
-25,500
-5% -$1.92K ﹤0.01% 447
2023
Q1 		$28.5K Buy
517,830
+82,566
+19% +$4.76K ﹤0.01% 615
2022
Q4 		$19.8K Hold
435,264
– – ﹤0.01% 685
2022
Q3 		$32K Buy
435,264
+166,864
+62% +$15.2K ﹤0.01% 781
2022
Q2 		$40K Buy
268,400
+16,600
+7% +$3.49K ﹤0.01% 742
2022
Q1 		$79K Hold
251,800
– – ﹤0.01% 823
2021
Q4 		$129K Buy
251,800
+85,500
+51% +$47.2K ﹤0.01% 776
2021
Q3 		$97K Hold
166,300
– – ﹤0.01% 781
2021
Q2 		$167K Buy
+166,300
New +$126K 0.01% 634

Periscope Capital's AEON.WS Position: Q2 2024 in Review

Periscope Capital sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 15,500 shares — an estimated $22.5K sold.

Periscope Capital first reported a position in AEON.WS in Q2 2021 and held it in 12 quarters. The position peaked at $167K in Q2 2021. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

  • Periscope Capital reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
  • Periscope Capital sold 15,500 AEON Biopharma Inc shares in Q2 2024, an estimated $22.5K.
  • Periscope Capital first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 12 quarters.
  • Periscope Capital's AEON Biopharma Inc position peaked at $167K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Periscope Capital's 13F filing for Q2 2024, filed 13 Aug 2024.